Embattled GlaxoSmithKline hit with another fraud probe

Britain's fraud agency on Tuesday said it had launched a probe into pharmaceutical giant GlaxoSmithKline, which is already subject of a series of investigations into alleged staff corruption.

The Serious Fraud Office (SFO) confirmed it had opened a "formal " into the London-based drugs manufacturer's commercial practices.

"GSK is committed to operating its business to the highest ethical standards and will continue to cooperate fully with the SFO," said a company spokesman, without providing further details.

GSK last month said first-quarter revenues had fallen 10 percent to £5.6 billion (6.9 billion euros, $9.4 billion) after a Chinese impacted sales growth at the company's emerging markets division.

In a further blow, Polish prosecutors in April said they had extended a probe into allegations that GSK bribed doctors into promoting one of its drugs.

The company is also investigating alleged corruption by staff at its pharmaceuticals division in Iraq.

GSK last year admitted that senior employees appeared to have breached Chinese law after Beijing authorities alleged that staff had bribed government officials, pharmaceutical industry groups, hospitals and doctors to promote sales.

add to favorites email to friend print save as pdf

Related Stories

Probe-hit GlaxoSmithKline announces profits slump

Apr 30, 2014

GlaxoSmithKline, the British drugs giant facing a series of probes into alleged staff corruption, announced sliding profits on Wednesday, one week after unveiling a group makeover.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments